Trial Profile
Metabolic Control of Type 2 Diabetes Patients Before and After Dietary Supplementation With the Probiotic Lactobacillus Reuteri DSM 17938 - a Pilot Study
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Limosilactobacillus reuteri (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Feb 2020 Status changed from recruiting to completed.
- 20 Jun 2012 New trial record